Resultats globals: 46 registres trobats en 0.04 segons.
Articles, 44 registres trobats
Documents de recerca, 2 registres trobats
Articles 44 registres trobats  1 - 10següentfinal  anar al registre:
1.
10 p, 563.7 KB Mortality risk prediction in elderly patients with cardiogenic shock : results from the CardShock study / Hongisto, Mari (Helsinki University Hospital) ; Lassus, Johan (Helsinki University Hospital) ; Tarvasmäki, Tuukka (Helsinki University Hospital) ; Sionis, Alessandro (Institut d'Investigació Biomèdica Sant Pau) ; Sans-Rosello, Jordi (Institut d'Investigació Biomèdica Sant Pau) ; Tolppanen, Heli (Helsinki University Hospital) ; Kataja, Anu (Helsinki University Hospital) ; Jäntti, Toni (Helsinki University Hospital) ; Sabell, Tuija (Helsinki University Hospital) ; Lindholm, Matias Greve (Zealand University Hospital) ; Banaszewski, Marek (National Institute of Cardiology) ; Silva Cardoso, Jose (University of Porto, São João University Medical Centre) ; Parissis, John (Attikon University Hospital) ; Di Somma, Salvatore (Sapienza University of Rome) ; Carubelli, Valentina (University and Civil Hospital of Brescia) ; Jurkko, Raija (Helsinki University Hospital) ; Masip, Josep (Hospital Sant Joan Despi Moisès Broggi, Consorci Sanitari Integral, University of Barcelona) ; Harjola, Veli-Pekka (Helsinki University Hospital) ; Universitat Autònoma de Barcelona
This study aimed to assess the utility of contemporary clinical risk scores and explore the ability of two biomarkers [growth differentiation factor-15 (GDF-15) and soluble ST2 (sST2)] to improve risk prediction in elderly patients with cardiogenic shock. [...]
2021 - 10.1002/ehf2.13224
ESC Heart Failure, Vol. 8 (january 2021) , p. 1398-1407  
2.
11 p, 1.2 MB Blood Biomarkers to Predict Long-Term Mortality after Ischemic Stroke / Ramiro, Laura (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Abraira, Laura (Universitat Autònoma de Barcelona. Departament de Medicina) ; Quintana, Manuel (Universitat Autònoma de Barcelona. Departament de Medicina) ; García-Rodríguez, Paula (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Santamarina, Estevo (Universitat Autònoma de Barcelona. Departament de Medicina) ; Álvarez-Sabín, José (Universitat Autònoma de Barcelona. Departament de Medicina) ; Zaragoza, Josep (Stroke Unit, Verge de la Cinta University Hospital, 43500 Tortosa, Spain) ; Hernández-Pérez, María (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Ustrell, Xavier (Hospital Universitari Joan XXIII de Tarragona) ; Lara, Blanca (Stroke Unit, Bellvitge University Hospital, 08907 Barcelona, Spain) ; Terceño, Mikel (Stroke Unit, Josep Trueta University Hospital, 17007 Girona, Spain) ; Bustamante, Alejandro (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Montaner, Joan (Hospital Universitari Vall d'Hebron. Institut de Recerca)
Stroke is a major cause of disability and death globally, and prediction of mortality represents a crucial challenge. We aimed to identify blood biomarkers measured during acute ischemic stroke that could predict long-term mortality. [...]
2021 - 10.3390/life11020135
Life, Vol. 11 (february 2021)  
3.
14 p, 892.1 KB Discovery of novel DNA methylation biomarkers for non-invasive sporadic breast cancer detection in the Latino population / Cappetta, M. (Departamento de Genética. Facultad de Medicina. Universidad de la República) ; Fernandez, L. (Departamento de Genética. Facultad de Medicina. Universidad de la República) ; Brignoni, L. (Departamento de Genética. Facultad de Medicina. Universidad de la República) ; Artagaveytia, N. (Departamento Básico de Medicina. Facultad de Medicina. Universidad de la República) ; Bonilla, C. (Population Health Sciences. Bristol Medical School. University of Bristol) ; López, Miguel (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Esteller, M. (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Bertoni, B. (Departamento de Genética. Facultad de Medicina. Universidad de la República) ; Berdasco, Maria (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Universitat Autònoma de Barcelona
Human diversity is one of the main pitfalls in the development of robust worldwide biomarkers in oncology. Epigenetic variability across human populations is associated with different genetic backgrounds, as well as variable lifestyles and environmental exposures, each of which should be investigated. [...]
2021 - 10.1002/1878-0261.12842
Molecular Oncology, Vol. 15 Núm. 2 (february 2021) , p. 473-486  
4.
15 p, 1.7 MB Epigenetic footprint enables molecular risk stratification of hepatoblastoma with clinical implications / Carrillo-Reixach, Juan (Institut Germans Trias i Pujol) ; Torrens, L. (Translational research in Hepatic Oncology. Liver Unit. Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS). Hospital Clínic. Universitat de Barcelona) ; Simón-Coma, Marina (Institut Germans Trias i Pujol) ; Royo, Laura (Institut Germans Trias i Pujol) ; Domingo-Sàbat, Montse (Institut Germans Trias i Pujol) ; Abril-Fornaguera, J. (Translational research in Hepatic Oncology. Liver Unit. Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS). Hospital Clínic. Universitat de Barcelona) ; Akers, N. (Department of Genetics and Genomic Sciences. The Icahn Institute for Genomics and Multiscale Biology. Icahn School of Medicine at Mount Sinai) ; Sala Llinas, Margarita (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Ragull, Sonia (Institut Germans Trias i Pujol) ; Arnal, Magdalena (Institut Hospital del Mar d'Investigacions Mèdiques) ; Villalmanzo, Núria (Institut Germans Trias i Pujol) ; Cairo, S. (Instituto di Ricerca Pediatrica. Corso Stati Uniti 4) ; Villanueva, A. (Chemoresistance and Predictive Factors Group. Program Against Cancer Therapeutic Resistance. Catalan Institute of Oncology (ICO). Bellvitge Biomedical Research Institute. L'Hospitalet del Llobregat) ; Kappler, R. (Department of Pediatric Surgery. Dr. von Hauner Children's Hospital. Ludwig-Maximilians-University Munich) ; Garrido-Portnou, Marta (Hospital Universitari Vall d'Hebron) ; Guerra, Laura (University Hospital La Paz. Pathology Department) ; Sábado, Constantino (Hospital Universitari Vall d'Hebron) ; Guillén, Ganriela (Hospital Universitari Vall d'Hebron) ; Mallo, Maria del Mar (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Piñeyro, David (Institut Germans Trias i Pujol) ; Vázquez-Vitali, María (Institut Germans Trias i Pujol) ; Kuchuk, O. (Mount Sinai Liver Cancer Program. Divisions of Liver Diseases. Tisch Cancer Institute. Icahn School of Medicine at Mount Sinai) ; Mateos, M.E. (Pediatric Oncology Unit. Department of Pediatrics. University Hospital Reina Sofía) ; Ramírez, G. (University Hospital Universitario Virgen del Rocío. Pediatric Oncology Department) ; Santamaría, M.L. (University Hospital La Paz. Pediatric Surgery Department) ; Mozo, Y. (University Hospital La Paz. Pediatric Oncology Department) ; Soriano, A. (Hospital Universitari Val d'Hebron. Institut de Recerca) ; Grotzer, M. (Department of Pediatric Oncology. University Children's Hospital Zurich. University of Zurich) ; Branchereau, S. (Bicêtre Hospital) ; de Andoin, N.G. (Pediatric Oncology. Hospital Universitario Donostia) ; López-Ibor, B. (Department of Pediatric Hematology and Oncology. HM Montepríncipe Hospital) ; López-Almaraz, R. (Pediatric Oncology and Hematology. Hospital Universitario Cruces) ; Salinas, J.A. (Division of Hematology-Oncology. Department of Pediatrics. Hospital Universitari Son Espases) ; Torres, B. (Medical Oncology Department. Pediatric Oncology Department. University Hospital La Fe) ; Hernández, F. (University Hospital La Paz. Pediatric Surgery Department) ; Uriz, J.J. (Pediatric Oncology. Hospital Universitario Donostia) ; Fabre, M. (Department of Pathology. Hôpital Universitaire Necker-Enfants Malades. Assistance Publique-Hôpitaux de Paris. Université Paris Descartes) ; Blanco, J. (Universitat de Vic. Universitat Central de Catalunya) ; Paris, C. (Stem Cell Transplant Unit. Hospital Luis Calvo Mackenna) ; Bajčiová, V. (Department of Pediatric Oncology. Childrens University Hospital Brno) ; Laureys, G. (Department of Pediatric Hematology. Oncology and Hematopoietic Stem Cell Transplantation. Ghent University Hospital) ; Masnou, Helena (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Clos, Ariadna (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Belendez, C. (Hospital Gregorio Marañón (Madrid)) ; Guettier, C. (Bicêtre Hospital) ; Sumoy, Lauro (Institut Germans Trias i Pujol) ; Planas, Ramón (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Jordà, Mireia (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Nonell, Lara (Institut Hospital del Mar d'Investigacions Mèdiques) ; Czauderna, P. (Department of Surgery and Urology for Children and Adolescents. Medical University of Gdansk) ; Morland, B. (Department of Oncology. Birmingham Women's and Children's Hospital) ; Sia, D. (Mount Sinai Liver Cancer Program. Divisions of Liver Diseases. Tisch Cancer Institute. Icahn School of Medicine at Mount Sinai) ; Losic, B. (Icahn Institute for Data Science and Genomic Technology. Icahn School of Medicine at Mount Sinai) ; Buendia, M.A. (INSERM. UMR 1193. Paul-Brousse Hospital. Hepatobiliary Centre) ; Sarrias, Maria-Rosa (Institut Germans Trias i Pujol) ; Llovet, J.M. (Institució Catalana de Recerca i Estudis Avançats (ICREA)) ; Armengol, Carolina (Institut Germans Trias i Pujol) ; Universitat Autònoma de Barcelona
Background & Aims: Hepatoblastoma (HB) is a rare disease. Nevertheless, it is the predominant pediatric liver cancer, with limited therapeutic options for patients with aggressive tumors. Herein, we aimed to uncover the mechanisms of HB pathobiology and to identify new biomarkers and therapeutic targets in a move towards precision medicine for patients with advanced HB. [...]
2020 - 10.1016/j.jhep.2020.03.025
Journal of Hepatology, Vol. 73 Núm. 2 (august 2020) , p. 328-341  
5.
15 p, 2.7 MB Expression Levels of an Alpha-Synuclein Transcript in Blood May Distinguish between Early Dementia with Lewy Bodies and Parkinson's Disease / Marsal-García, Laura (Institut Germans Trias i Pujol) ; Campdelacreu, Jaume (Hospital Universitari Bellvitge. Servei de Neurologia) ; Vilas, Dolores (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Ispierto, Lourdes (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Gascón Bayarri, Jordi (Hospital Universitari Bellvitge. Servei de Neurologia) ; Reñé, Ramón (Hospital Universitari Bellvitge. Servei de Neurologia) ; Álvarez, Ramiro (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Beyer, Katrin (Institut Germans Trias i Pujol) ; Urbizu, Aintzane (Institut Germans Trias i Pujol) ; Arnaldo, Laura (Institut Germans Trias i Pujol) ; Universitat Autònoma de Barcelona
Lewy body diseases (LBD) including dementia with Lewy bodies (DLB) and Parkinson disease (PD) are characterized by alpha-synuclein pathology. DLB is difficult to diagnose and peripheral biomarkers are urgently needed. [...]
2021 - 10.3390/ijms22020725
International journal of molecular sciences, Vol. 22 Núm. 2 (2021) , p. 725  
6.
8 p, 519.2 KB A European multicentre and open-label controlled randomized trial to evaluate the efficacy of S equential treatment with TAcrolimus-Rituximab versus steroids plus cyclophosphamide in patients with primary MEmbranous Nephropathy : the STARMEN study / Rojas-Rivera, Jorge (Spanish Renal Research Network (REDINREN)) ; Fernández-Juárez, Gema (Hospital Universitario Fundación Alcorcón) ; Ortiz, Alberto (Spanish Renal Research Network (REDINREN)) ; Hofstra, Julia (Radboud University Nijmegen Medical Center) ; Gesualdo, Loreto (Struttura Complessa di Nefrologia Dialisi e Trapianto Ospedaliero-Universitaria) ; Tesar, Vladimir (1st School of Medicine, Charles University and General University Hospital) ; Wetzels, Jack (Radboud University Nijmegen Medical Center) ; Segarra, Alfons (Hospital Universitari Vall d'Hebron) ; Egido, Jesus (IIS-Fundación Jiménez Díaz, School of Medicine, Universidad Autónoma de Madrid (UAM) and FRIAT) ; Praga, Manuel (Hospital Universitario 12 de Octubre, Universidad Complutense de Madrid) ; Universitat Autònoma de Barcelona
Patients with primary membranous nephropathy (MN) and persistent nephrotic syndrome have a high risk of progression to end-stage renal disease. The Ponticelli protocol (steroids with alkylating agents) is the most effective immunosuppressive therapy for this condition, but it has severe adverse effects. [...]
2015 - 10.1093/ckj/sfv075
Clinical Kidney Journal, Vol. 8 (september 2015) , p. 503-510  
7.
11 p, 515.9 KB Study of the Spanish Society of Medical Oncology (SEOM) on the access to oncology drugs and predictive biomarkers in Spain / Rodríguez-Lescure, A. (Hospital General Universitario de Elche. Medical Oncology Department) ; de la Peña, F. A. (Hospital Universitario Morales Meseguer. Haematology and Medical Oncology Department) ; Aranda, E. (Maimonides Institute of Biomedical Research (IMIBIC), Reina Sofía Hospital, University of Córdoba, Spanish Cancer Network (RTICC), Instituto de Salud Carlos III. Oncology Department) ; Calvo, A. (Hospital General Universitario Gregorio Marañón) ; Felip, E. (Hospital Universitari Vall d'Hebron) ; Garrido, P. (Hospital Universitario Ramón Y Cajal. Medical Oncology Department) ; Vera, R. (Complejo Hospitalario de Navarra, Navarrabiomed, IdISNA. Medical Oncology Department) ; Universitat Autònoma de Barcelona
The Spanish Society of Medical Oncology (SEOM) has carried out a study to analyse the conditions of access to oncology drugs in clinical practice in Spain. For the first time, the access of predictive biomarkers has also been analyzed. [...]
2020 - 10.1007/s12094-020-02366-y
Clinical & Translational Oncology, Vol. 22 (june 2020) , p. 2253-2263  
8.
11 p, 3.6 MB Changes in salivary analytes in canine parvovirus : A high-resolution quantitative proteomic study / Franco-Martínez, Lorena (Universidad de Murcia. Interdisciplinary Laboratory of Clinical Analysis Interlab-UMU. Regional Campus of International Excellence Mare Nostrum.) ; Tvarijonaviciute, Asta (Universidad de Murcia. Interdisciplinary Laboratory of Clinical Analysis Interlab-UMU. Regional Campus of International Excellence Mare Nostrum.) ; Horvatić, Anita (University of Zagreb. Internal Diseases Clinic, Faculty of Veterinary Medicine) ; Guillemin, Nicolas (University of Zagreb. Internal Diseases Clinic, Faculty of Veterinary Medicine) ; Cerón, José Joaquín (Universidad de Murcia. Interdisciplinary Laboratory of Clinical Analysis Interlab-UMU. Regional Campus of International Excellence Mare Nostrum.) ; Escribano, Damián (Universitat Autònoma de Barcelona. Departament de Sanitat i d'Anatomia Animals) ; Eckersall, David (University of Glasgow. Institute of Biodiversity, Animal Health and Comparative Medicine) ; Kocatürk, Meriç (Uludag University. Department of Internal Medicine. Faculty of Veterinary Medicine) ; Yilmaz, Zeki (Uludag University. Department of Internal Medicine. Faculty of Veterinary Medicine) ; Lamy, Elsa (Universidad de Evora. ICAAM - Institute of Mediterranean Agricultural and Environmental Sciences) ; Martínez-Subiela, Silvia (Universidad de Murcia. Interdisciplinary Laboratory of Clinical Analysis Interlab-UMU. Regional Campus of International Excellence Mare Nostrum.) ; Mrljak, Vladimir (University of Zagreb. Internal Diseases Clinic, Faculty of Veterinary Medicine)
The present study evaluated the changes in salivary proteome in parvoviral enteritis (PVE) in dogs through a high-throughput quantitative proteomic analysis. Saliva samples from healthy dogs and dogs with severe parvovirosis that survived or perished due to the disease were analysed and compared by Tandem Mass Tags (TMT) analysis. [...]
2018 - 10.1016/j.cimid.2018.09.011
Comparative Immunology, Microbiology and Infectious Diseases, Vol. 60 October (2018) , p. 1-10  
9.
13 p, 2.1 MB Increased plasma levels of galectin-1 in pancreatic cancer : potential use as biomarker / Martinez-Bosch, Neus (Institut Hospital del Mar d'Investigacions Mèdiques) ; Barranco, Luis E. (Institut Hospital del Mar d'Investigacions Mèdiques) ; Orozco, Carlos A. (Institut Hospital del Mar d'Investigacions Mèdiques) ; Moreno, Mireia (Institut Hospital del Mar d'Investigacions Mèdiques) ; Visa, Laura (Hospital del Mar (Barcelona)) ; Iglesias, Mar (Universitat Autònoma de Barcelona. Departament de Ciències Morfològiques) ; Oldfield, Lucy (Department of Molecular and Clinical Cancer Medicine, Institute of Translational Medicine, University of Liverpool, Liverpool, UK) ; Neoptolemos, John P. (Department of General Surgery, University of Heidelberg, Heidelberg, Germany) ; Greenhalf, William (Department of Molecular and Clinical Cancer Medicine, Institute of Translational Medicine, University of Liverpool, Liverpool, UK) ; Earl, Julie (Department of Medical Oncology, Ramon y Cajal University Hospital, CIBERONC, IRYCIS, Alcala University, Madrid, Spain) ; Carrato, Alfredo (Department of Medical Oncology, Ramon y Cajal University Hospital, CIBERONC, IRYCIS, Alcala University, Madrid, Spain) ; Costello, Eithne (Department of Molecular and Clinical Cancer Medicine, Institute of Translational Medicine, University of Liverpool, Liverpool, UK) ; Navarro, Pilar (Institute of Biomedical Research of Barcelona (IIBB-CSIC), Barcelona, Spain)
Pancreatic ductal adenocarcinoma (PDA) is the most frequent type of pancreatic cancer and one of the deadliest diseases overall. New biomarkers are urgently needed to allow early diagnosis, one of the only factors that currently improves prognosis. [...]
2018 - 10.18632/oncotarget.26034
Oncotarget, Vol. 9 (august 2018) , p. 32984-32996  
10.
15 p, 1.0 MB An up-to-date catalog of available urinary biomarkers for the surveillance of non-muscle invasive bladder cancer / Soria, Francesco (Division of Urology, Department of Surgical Sciences, San Giovanni Battista Hospital, University of Studies of Torino, Turin, Italy) ; Droller, Michael J. (The Mount Sinai Medical Center. Department of Urology) ; Lotan, Yair (University of Texas Southwestern Medical Center. Department of Urology) ; Gontero, Paolo (Division of Urology, Department of Surgical Sciences, San Giovanni Battista Hospital, University of Studies of Torino, Turin, Italy) ; D'Andrea, David (Medical University of Vienna. Department of Urology and Comprehensive Cancer Center, Vienna General Hospital) ; Gust, Kilian M. (Medical University of Vienna. Department of Urology and Comprehensive Cancer Center, Vienna General Hospital) ; Rouprêt, Morgan (Assistance Publique-Hôpitaux de Paris Sorbonne Université. Department of Urology, Hôpital Pitié-Salpétrière) ; Babjuk, Marek (Medical University of Vienna. Department of Urology and Comprehensive Cancer Center, Vienna General Hospital) ; Palou, Joan (Institut d'Investigació Biomèdica Sant Pau) ; Shariat, Shahrokh F. (Karl Landsteiner Institute of Urology and Andrology, Vienna, Austria) ; Universitat Autònoma de Barcelona
With the advent of novel genomic and transcriptomic technologies, new urinary biomarkers have been identified and tested for bladder cancer (BCa) surveillance. To summarize the current status of urinary biomarkers for the detection of recurrence and/or progression in the follow-up of non-muscle invasive BCa patients, and to assess the value of urinary biomarkers in predicting response to intravesical Bacillus Calmette-Guerin (BCG) therapy. [...]
2018 - 10.1007/s00345-018-2380-x
World Journal of Urology, Vol. 36 (june 2018) , p. 1981-1995  

Articles : 44 registres trobats   1 - 10següentfinal  anar al registre:
Documents de recerca 2 registres trobats  
1.
220 p, 3.9 MB Búsqueda de Biomarcadores asociados a la conversión a esclerosis múltiple en pacientes con síndromes clínicos aislados / Cantó Puig, Ester ; Comabella López, Manuel, dir. ; Montalbán Gairín, Xavier, dir. (Universitat Autònoma de Barcelona. Departament de Medicina) ; Jaraquemada, Dolores, tut. (Universitat Autònoma de Barcelona. Departament de Biologia Cel·lular, de Fisiologia i d'Immunologia) ; Universitat Autònoma de Barcelona. Departament de Biologia Cel·lular, de Fisiologia i d'Immunologia
Aproximadamente el 85% de los pacientes con esclerosis múltiple (EM) inician la enfermedad con un síndrome clínico aislado (CIS), pero se ha descrito que entre un 30 y un 85% de los pacientes que presentan un CIS finalmente desarrollan EM clínicamente definida (EMCD). [...]
In about 85% of patients with multiple sclerosis (MS) the disease starts with a clinically isolated syndrome (CIS), but only 30 to 85% of patients with CIS finally develop clinically definite MS (CDMS). [...]

[Barcelona] : Universitat Autònoma de Barcelona, 2015  
2.
1 p, 689.8 KB HE4 as biomarker for ovarian cancer : a critical review / Pagès Martínez, Ernest ; Blanco Vaca, Francisco, dir. (Universitat Autònoma de Barcelona. Departament de Bioquímica i de Biologia Molecular) ; Universitat Autònoma de Barcelona. Facultat de Biociències
2014
Grau en Bioquímica [814]  

Us interessa rebre alertes sobre nous resultats d'aquesta cerca?
Definiu una alerta personal via correu electrònic o subscribiu-vos al canal RSS.